Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ruba, Ayyub"'
Autor:
Julia Lowin, Mickael Basson, Florence Chartier, Stéphane Roze, Kirsi Norrbacka, Donna Wright, Dionysios Ntais, Ruba Ayyub
Publikováno v:
Diabetes Therapy
Introduction Dulaglutide is a novel onceweekly administered glucagon-like peptide 1 receptor agonist (GLP-1 RA) for the management of type 2 diabetes mellitus (T2DM). The objective of this analysis was to estimate the cost-effectiveness of dulaglutid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::199934a6a544fd5c45bf91eaded2bbb2
https://doi.org/10.1007/s13300-017-0321-0
https://doi.org/10.1007/s13300-017-0321-0
Autor:
Tatiana, Dilla, Dimitra, Alexiou, Ismini, Chatzitheofilou, Ruba, Ayyub, Julia, Lowin, Kirsi, Norrbacka
Publikováno v:
Journal of medical economics. 20(5)
Dulaglutide 1.5 mg once weekly is a novel glucagon-like peptide 1 (GLP-1) receptor agonist, for the treatment of type two diabetes mellitus (T2DM). The objective was to estimate the cost-effectiveness of dulaglutide once weekly vs liraglutide 1.8 mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a43654c5f8294ef8bd6a60a190ce1101
https://pubmed.ncbi.nlm.nih.gov/28008768
https://pubmed.ncbi.nlm.nih.gov/28008768